期刊
HEART LUNG AND CIRCULATION
卷 22, 期 2, 页码 110-115出版社
ELSEVIER SCIENCE INC
DOI: 10.1016/j.hlc.2012.09.001
关键词
Accelerated chest pain pathway; Chest pain unit; Non-cardiac chest pain; Acute coronary syndrome
资金
- Ministry of Health, New Zealand
Background: A chest pain unit (CPU) for management of patients with chest pain at low to intermediate risk for acute coronary syndrome (ACS) appears safe and cost-effective. We report our experience with a CPU from March 2005 to July 2009. Methods: Prospective audit of patients presenting with chest pain suggestive of ACS but no high risk features and managed using a CPU, which included; serial cardiac troponins and electrocardiography and exercise tolerance test (ETT) if indicated. Outcomes assessed included three-month readmission rate and one year mortality. Results: 2358 patients were managed according to the CPU. Mean age 56 years (17-96 years), 59% men and median stay of 22 h (IQR 17-26 h). 1933 (82%) were diagnosed as non-cardiac chest pain. 1741 (74%) patients had an ETT. Median time from triage to ETT was 21 h (IQR 16-24 h). 64 (2.7%) were readmitted within three months. The majority of readmissions, 39 (61 /0) were for a non-cardiac cause. Twenty patients (1%) were readmitted with ACS. There was no cardiac death after one year of being discharged as non-cardiac chest pain. Conclusions: This study confirms that a CPU with high usage of predischarge ETT is a safe and effective way of excluding ACS in patients without high risk features in a New Zealand setting. (Heart, Lung and Circulation 2013;22:110-115) (C) 2012 Australian and New Zealand Society of Cardiac and Thoracic Surgeons (ANZSCTS) and the Cardiac Society of Australia and New Zealand (CSANZ). Published by Elsevier Inc. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据